Response of Brain Mets From PIK3CA-Mutant BC to Alpelisib Response of Brain Mets From PIK3CA-Mutant BC to Alpelisib

Is the newly approved PI3K-inhibitor alpelisib a safe and effective option for breast cancer patients with brain metastases? A case series provides insight into the treatment response.JCO Precision Oncology

Source: Medscape Today Headlines - July 30, 2020 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news